Failure-Free Survival and Radiotherapy in Patients With Newly Diagnosed Nonmetastatic Prostate Cancer
Nicholas D. James1,2, Melissa Spears3, Noel W. Clarke4, David P. Dearnaley5, Malcolm D. Mason6, Chris Parker5, A.W.S. Ritchie3, John M. Russell7, Francesca Schiavone3, Gerhardt Attard5, Johann S. de Bono5, Alison Birtle8, Daniel S. Engeler9, Tony Elliott10, David Matheson11, Joe M. O’Sullivan12, Delia Pudney13, Narayanan Srihari14, Jan Wallace15, Jim Barber6, Isabel Syndikus16, Mahesh Parmar3, Matthew R. Sydes3
1Warwick Medical School, University of Warwick, Coventry, United Kingdom
2Warwick Medical School, University of Warwick, Coventry, United Kingdom2University Hospitals Birmingham NHS Foundation Trust, The Medical School, University of Birmingham, Birmingham, United Kingdom
3Medical Research Council Clinical Trials Unit, University College, London, United Kingdom
4Department of Urology, Christie NHS Foundation Trust, Manchester, United Kingdom
5Institute of Cancer Research and Royal Marsden NHS Foundation Trust, London, United Kingdom
6Velindre Hospital, Cardiff, United Kingdom
7Institute of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom
8Royal Preston Hospital, Preston, United Kingdom.
9Cantonal Hospital St. Gallen, St. Gallen, Switzerland
10Greater Manchester Group, Manchester, United Kingdom
11Leeds Beckett University, Leeds, United Kingdom
12Belfast City Hospital, Belfast, United Kingdom
13Singleton Hospital, Swansea, United Kingdom
14Royal Shrewsbury Hospital, Shrewsbury, United Kingdom
15Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom
16CCO Liverpool Warrington Aintree, Liverpool, United Kingdom